Fig. 3
From: UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370
UBQLN4 is overexpressed in HCC tissues and associated with clinical pathological features of HCC patients. a Expression of UBQLN4 in HCC tissues and adjacent non-tumor tissues was detected by western blot. b HCC tissues from our hospital were detected by IHC and 1–5 points based on dyeing strength. c, d Relationship between expression of UBQLN4 and clinical pathological features of HCC patients (including TNM stage, poor histological grade, large tumor size and vascular invasion) was analyzed according to the IHC score. e Kaplan–meier analysis was used to analyze relationship between UBQLN4 expression and overall survival of HCC patients. *p < 0.05, **p < 0.01